TC
AGTC

TFS Capital’s Applied Genetic Technologies Corporation AGTC Stock Holding History

TFS Capital’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-38,814
Closed -$198K – 425
2017
Q2 		$198K Sell
38,814
-21,201
-35% -$119K 0.08% 454
2017
Q1 		$414K Buy
60,015
+36,052
+150% +$282K 0.13% 282
2016
Q4 		$224K Sell
23,963
-770
-3% -$6.93K 0.06% 488
2016
Q3 		$242K Sell
24,733
-87,204
-78% -$1.18M 0.06% 483
2016
Q2 		$1.58M Sell
111,937
-56,587
-34% -$883K 0.29% 56
2016
Q1 		$2.36M Sell
168,524
-124,112
-42% -$1.82M 0.34% 26
2015
Q4 		$5.97M Buy
292,636
+233,442
+394% +$3.6M 0.64% 10
2015
Q3 		$778K Sell
59,194
-5,343
-8% -$88.6K 0.08% 403
2015
Q2 		$990K Buy
64,537
+9,021
+16% +$173K 0.1% 344
2015
Q1 		$1.11M Buy
+55,516
New +$1.24M 0.11% 311
2014
Q4 		– Sell
-17,495
Closed -$326K – 1196
2014
Q3 		$326K Buy
+17,495
New +$317K 0.03% 725

Other funds holding AGTC

IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TFS Capital's AGTC Position: Q3 2017 in Review

TFS Capital sold out of Applied Genetic Technologies Corporation (AGTC) in Q3 2017, closing a stake of 38,814 shares — an estimated $198K sold.

TFS Capital first reported a position in AGTC in Q3 2014 and held it in 11 quarters. The position peaked at $5.97M in Q4 2015. 67 funds tracked by Wall St. Rank hold AGTC as of Q3 2017.

  • TFS Capital reported no remaining Applied Genetic Technologies Corporation position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 38,814 Applied Genetic Technologies Corporation shares in Q3 2017, an estimated $198K.
  • TFS Capital first reported a position in Applied Genetic Technologies Corporation in Q3 2014 and held it in 11 quarters.
  • TFS Capital's Applied Genetic Technologies Corporation position peaked at $5.97M in Q4 2015.
  • 67 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.